Document Detail

Correlates of N-terminal prohormone brain natriuretic peptides in African Americans with hypertensive chronic kidney disease: the African American Study of Kidney Disease and Hypertension.
MedLine Citation:
PMID:  18824845     Owner:  NLM     Status:  MEDLINE    
BACKGROUND/AIMS: The N-amino-terminal fragment of the prohormone B-type natriuretic peptide (NT-proBNP) is a marker of cardiac stress and elevated levels are indicative of heart failure. Few correlates of NT-proBNP levels have been identified in persons with moderate chronic kidney disease (CKD), and data from those without heart failure and from African Americans are especially limited. METHODS: The African American Study of Kidney Disease and Hypertension (AASK) enrolled nondiabetic African Americans with hypertensive kidney disease (glomerular filtration rate [GFR] = 20-65 ml/min/1.73 m(2)) and no evidence of clinical heart failure. NT-proBNP was measured in 982 AASK participants. RESULTS: In unadjusted analyses, GFR (r = -0.39; p < 0.001), hematocrit (r = -0.21; p < 0.001) and body mass index (BMI; r = -0.07; p = 0.04) were inversely correlated, and systolic blood pressure (r = 0.30; p < 0.001) and log UPCR (r = 0.32; p < 0.001) were positively correlated with log NT-proBNP levels. After adjustment for potential confounders, lower GFR and hematocrit and higher systolic blood pressure and protein:creatinine ratio remained significantly associated with higher NT-proBNP. CONCLUSION: Lower GFR and hematocrit, and higher urinary protein excretion may be associated with volume expansion in CKD. These results suggest that these processes are associated with increased NT-proBNP in CKD and may play a role in the development of heart failure.
S Yi; G Contreras; E R Miller; L J Appel; B C Astor
Related Documents :
10413065 - Effects of rilmenidine on stress-induced peak blood pressure and renal function.
2137295 - Native tubular fluid attenuates anf-induced inhibition of tubuloglomerular feedback.
9386305 - The vascular pole of the renal glomerulus of rat.
24010465 - Pressure-induced unconventional superconducting phase in the topological insulator bi_{...
17544885 - Increasing cardiac output by epinephrine after cardiac surgery: effects on indocyanine ...
22282885 - Ambulatory systolic-diastolic pressure regression index as a predictor of clinical even...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2008-09-29
Journal Detail:
Title:  American journal of nephrology     Volume:  29     ISSN:  1421-9670     ISO Abbreviation:  Am. J. Nephrol.     Publication Date:  2009  
Date Detail:
Created Date:  2009-03-27     Completed Date:  2009-05-21     Revised Date:  2010-09-21    
Medline Journal Info:
Nlm Unique ID:  8109361     Medline TA:  Am J Nephrol     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  292-8     Citation Subset:  IM    
Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, Md., USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
African Americans / statistics & numerical data*
Body Mass Index
Creatinine / urine
Glomerular Filtration Rate
Heart Failure / blood,  ethnology
Hypertension, Renal / blood*,  ethnology*
Middle Aged
Natriuretic Peptide, Brain / blood*
Peptide Fragments / blood*
Proteinuria / blood,  ethnology
Renal Insufficiency, Chronic / blood*,  ethnology*
Risk Factors
Grant Support
2P20 R11104//PHS HHS; 5M01 RR00071/RR/NCRR NIH HHS; DK2818-02./DK/NIDDK NIH HHS; M01 00032//PHS HHS; M01 RR00052/RR/NCRR NIH HHS; M01 RR00827/RR/NCRR NIH HHS; M01-RR00080/RR/NCRR NIH HHS; P20-RR11145/RR/NCRR NIH HHS
Reg. No./Substance:
0/Peptide Fragments; 0/pro-brain natriuretic peptide (1-76); 114471-18-0/Natriuretic Peptide, Brain; 60-27-5/Creatinine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Endogenous hepatocyte growth factor attenuates inflammatory response in glycerol-induced acute kidne...
Next Document:  Iron supplementation during treatment with erythropoiesis-stimulating agents for cancer-related anem...